EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Exploring the Anticancer Potential of Novel Piperidine‐Embedded Isoxazol–Triazole Conjugates Against MCF‐7 Human Breast Adenocarcinoma Cell Line: Design, Synthesis, In Silico, and In Vitro Investigations

Jay R Ghonia iD, Jigisha Parikh, Bharatkumar Z Dholakiya iD

Chemistry & Biodiversity · 2026

DOI: 10.1002/cbdv.71702 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Jay R Ghonia und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Sardar Vallabhbhai National Institute of Technology, Surat, Gujarat, India. Hauptthemen laut MEDLINE: Triazoles, Piperidines, Antineoplastic Agents, Drug Design. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer remains a major global health challenge, particularly as several tumors develop resistance to current therapies. Although doxorubicin is widely used to treat various cancers, its effectiveness is often limited by adverse effects, including cardiotoxicity and nephrotoxicity, which restrict its dosing. In search of safer and more effective options, a series of novel piperidine–embedded isoxazol–triazole conjugates ( 6a‐6o ) were designed, synthesized, and biologically evaluated against the MCF‐7 cell line in this study. The synthesized compounds 6a‐6o were characterized using FTIR, HRMS, and 1 H and 13 C NMR spectroscopy analysis to confirm their structure and verify successful synthesis. The GI 50 (Growth Inhibition 50%) values of synthesized compounds 6a‐6o were determined using the SRB assay. Among all synthesized compounds, 6m exhibited the most potent antiproliferative activity against MCF‐7 cells, having GI50 5), comparable to adriamycin (doxorubicin, GI 50

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriazolesPiperidinesAntineoplastic AgentsDrug DesignIsoxazolesBreast NeoplasmsHumansMCF-7 CellsCell ProliferationDrug Screening Assays, AntitumorStructure-Activity RelationshipFemaleMolecular StructureDose-Response Relationship, Drug

Stichwörter der Autor:innen

anti‐breast cancer activityin silico evaluationisoxazolpiperidinetriazole

Substanzen

TriazolesPiperidinesAntineoplastic AgentsIsoxazolespiperidine

Autor:innen und Institutionen

  • Department of Chemistry, Sardar Vallabhbhai National Institute of Technology, Surat, Gujarat, India.
  • Department of Chemical Engineering, Sardar Vallabhbhai National Institute of Technology, Surat, Gujarat, India.

ORCID-Profile: Jay R Ghonia, Bharatkumar Z Dholakiya

Zitieren

APA

Ghonia, J. R., Parikh, J., & Dholakiya, B. Z. (2026). Exploring the Anticancer Potential of Novel Piperidine‐Embedded Isoxazol–Triazole Conjugates Against MCF‐7 Human Breast Adenocarcinoma Cell Line: Design, Synthesis, In Silico, and In Vitro Investigations. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.71702

Vancouver

Ghonia JR, Parikh J, Dholakiya BZ. Exploring the Anticancer Potential of Novel Piperidine‐Embedded Isoxazol–Triazole Conjugates Against MCF‐7 Human Breast Adenocarcinoma Cell Line: Design, Synthesis, In Silico, and In Vitro Investigations. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.71702

BibTeX
@article{Ghonia2026,
  author = {Ghonia, Jay R and Parikh, Jigisha and Dholakiya, Bharatkumar Z},
  title = {Exploring the Anticancer Potential of Novel Piperidine‐Embedded Isoxazol–Triazole Conjugates Against MCF‐7 Human Breast Adenocarcinoma Cell Line: Design, Synthesis, In Silico, and In Vitro Investigations},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  doi = {10.1002/cbdv.71702}
}
Kostenlos starten →